These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7861485)

  • 1. Carcinoma in situ of the bladder.
    Hudson MA; Herr HW
    J Urol; 1995 Mar; 153(3 Pt 1):564-72. PubMed ID: 7861485
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
    Coon JS; McCall A; Miller AW; Farrow GM; Weinstein RS
    Cancer; 1985 Aug; 56(4):797-804. PubMed ID: 4016671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.
    Jakse G; Hofstädter F
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S74-8. PubMed ID: 6640839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of ABO(H) isoantigen expression in bladder tumors.
    Srinivas V; Orihuela E; Lloyd KO; Old LJ; Whitmore WF
    J Urol; 1985 Jan; 133(1):25-8. PubMed ID: 3964875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
    Hammou JC; Fella C; Vacant J
    Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
    [No Abstract]   [Full Text] [Related]  

  • 10. Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra.
    Kurth KH; Schellhammer PF; Okajima E; Akdas A; Jakse G; Herr HW; Calais da Silva F; Fukushima S; Nagayama T
    Int J Urol; 1995 Jun; 2 Suppl 2():8-22. PubMed ID: 7553309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinoma in situ of the urinary bladder. A review].
    Tveter KJ; Fosså SD; Odegaard A
    Tidsskr Nor Laegeforen; 1981 Sep; 101(25):1378-80. PubMed ID: 7339923
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinoma in situ of the urinary bladder: clinical experience and preliminary study of Thomsen-Friedenreich antigen].
    Sasaki K; Maru A; Sakashita S; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):269-77. PubMed ID: 6379252
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression.
    Soloway MS; Myers GH; Krueger G
    Urology; 1974 Apr; 3(4):437-43. PubMed ID: 4822692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bladder carcinoma in situ].
    Jakse G
    Helv Chir Acta; 1982 Aug; 49(3-4):329-34. PubMed ID: 7129898
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder carcinoma in situ: conservative versus aggressive approach.
    Steg A; Boiteux JP
    Prog Clin Biol Res; 1984; 153():263-74. PubMed ID: 6473399
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of A, B or O (H) surface antigen specificity: carcinoma in situ and non-malignant lesions of the bladder.
    Emmott RC; Droller MJ; Javadpour N
    J Urol; 1981 Jan; 125(1):32-5. PubMed ID: 6162036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid carcinoma of the bladder: a case report.
    Takashi M; Sakata T; Nakano Y; Nagai T; Miyake K
    Hinyokika Kiyo; 1992 Jan; 38(1):67-70. PubMed ID: 1546573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of prostate specific antigen from bacillus Calmette-Guerin-induced granulomatous prostatitis.
    Bahnson RR
    J Urol; 1991 Nov; 146(5):1368-9. PubMed ID: 1719246
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoma in situ of the bladder.
    Herr HW
    Semin Urol; 1983 Feb; 1(1):15-22. PubMed ID: 6679095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.